Report overview
The IVD product portfolio includes devices that assist in clinical chemistry & immunoassays, urinalysis, point-of-care testing, and patient self-testing devices.
This report aims to provide a comprehensive presentation of the global market for Lab Automation for In-vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lab Automation for In-vitro Diagnostics. This report contains market size and forecasts of Lab Automation for In-vitro Diagnostics in global, including the following market information:
Global Lab Automation for In-vitro Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Lab Automation for In-vitro Diagnostics Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Lab Automation for In-vitro Diagnostics companies in 2022 (%)
The global Lab Automation for In-vitro Diagnostics market was valued at US$ 5274 million in 2022 and is projected to reach US$ 8535.7 million by 2029, at a CAGR of 7.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Automated Plate Handler Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lab Automation for In-vitro Diagnostics include Cognex Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Inc, Abbott, PerkinElmer, Inc, Tecan Group Ltd and BD, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lab Automation for In-vitro Diagnostics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lab Automation for In-vitro Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, by Type, 2022 (%)
Automated Plate Handler
Automated Liquid Handler
Robotic Arm
Others
Global Lab Automation for In-vitro Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, by Application, 2022 (%)
Academic
Laboratory
Others
Global Lab Automation for In-vitro Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Lab Automation for In-vitro Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lab Automation for In-vitro Diagnostics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lab Automation for In-vitro Diagnostics revenues share in global market, 2022 (%)
Key companies Lab Automation for In-vitro Diagnostics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Lab Automation for In-vitro Diagnostics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cognex Corporation
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc
Danaher Corporation
Agilent Technologies, Inc
Abbott
PerkinElmer, Inc
Tecan Group Ltd
BD
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lab Automation for In-vitro Diagnostics, market overview.
Chapter 2: Global Lab Automation for In-vitro Diagnostics market size in revenue and volume.
Chapter 3: Detailed analysis of Lab Automation for In-vitro Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lab Automation for In-vitro Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lab Automation for In-vitro Diagnostics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
